Letermovir(CAS: 917389-32-3)

Letermovir (CAS: 917389-32-3) is a small-molecule antiviral drug. It is used for the prevention of cytomegalovirus (CMV) disease in patients who are immunocompromised, particularly those undergoing kidney transplantation. Letermovir inhibits the viral DNA polymerase, which is essential for viral replication.

Letermovir (CAS: 917389-32-3) is primarily used for the prophylaxis of CMV disease in immunocompromised patients, especially those undergoing kidney transplantation. It is also used in the treatment of CMV infections where other antiviral drugs are not suitable or have failed.

Letermovir (CAS: 917389-32-3) is generally considered safe when used as directed. However, like all medications, it may cause side effects. Common side effects include headache, nausea, and diarrhea. Patients should consult their healthcare provider if they experience any adverse reactions.

Letermovir (CAS: 917389-32-3) should be stored at room temperature, between 15°C and 30°C (59°F and 86°F). It should be kept away from direct sunlight and moisture. Store the medication in its original container and protect it from light exposure to maintain its efficacy.